NCT00092625View on ClinicalTrials.gov

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

PHASE3CompletedINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

August 31, 2004

Conditions
HypercholesterolemiaCoronary Disease
Interventions
DRUG

MK0653, ezetimibe

DRUG

Comparator: ezetimibe, placebo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092625 - Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803) | Biotech Hunter | Biotech Hunter